Placental COL1A2 and COL11A1 mRNA Expression and Collagen Type I Distribution in Spontaneous Preterm Birth, Preeclampsia, and HELLP Syndrome
International Journal of Molecular Sciences · 10.11.2026 · 27 (22) · 10064
DOI: 10.3390/ijms272210064 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.11.2026. Verfasst von Mandy Busse und 9 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The placental extracellular matrix undergoes continuous remodeling during gestation; however, collagen-related changes in spontaneous preterm birth (sPTB), preeclampsia (PE), and HELLP syndrome remain incompletely characterized. To this end, we compared placental COL1A2 and COL11A1 mRNA expression by RT-qPCR, collagen type I distribution by immunohistochemistry, and cytokine release from placental explants in pregnancies with sPTB (n = 13), PE (n = 10), HELLP syndrome (n = 10), and uncomplicated term deliveries (n = 8). COL11A1 mRNA expression levels were elevated in sPTB compared to the other study groups, while COL1A2 mRNA expression exhibited significant differences between sPTB and HELLP. Furthermore, placental explants from sPTB pregnancies exhibited higher levels of IL-6 and IL-8 release compared to those from PE and HELLP pregnancies, though not significantly higher than those from term controls. Type I collagen staining was reduced in the stem and intermediate villi of patients with preeclampsia (PE), while staining of terminal villi was observed more often in patients with HELLP and sPTB. Exploratory analyses revealed no significant COL1A2 or COL11A1 mRNA disparities between infection-associated (n = 6) and other sPTB cases (n = 7). These findings identify distinct associations between placental collagen-related measurements and clinical pregnancy outcomes. The limitations of the study include the modest sample size, gestational-age differences relative to term controls, and the absence of target-specific protein validation. These limitations preclude causal or biomarker-specific conclusions.
Zitieren
APA
Busse, M., Mészáros, J., Grabar, V., Gennari, P., Tenbeitel, L., Wiese-Rischke, C., Uehre, G. M., Helal, A., Taube, E. T., & Ignatov, A. (2026). Placental COL1A2 and COL11A1 mRNA Expression and Collagen Type I Distribution in Spontaneous Preterm Birth, Preeclampsia, and HELLP Syndrome. International Journal of Molecular Sciences, 27(22), 10064. https://doi.org/10.3390/ijms272210064
Vancouver
Busse M, Mészáros J, Grabar V, Gennari P, Tenbeitel L, Wiese-Rischke C, et al. Placental COL1A2 and COL11A1 mRNA Expression and Collagen Type I Distribution in Spontaneous Preterm Birth, Preeclampsia, and HELLP Syndrome. International Journal of Molecular Sciences. 2026;27(22):10064. doi:10.3390/ijms272210064
BibTeX
@article{Busse2026,
author = {Busse, Mandy and Mészáros, József and Grabar, Valeriia and Gennari, Paolo and Tenbeitel, Lilli and Wiese-Rischke, Cornelia and Uehre, Gina Marie and Helal, Ahmad and Taube, Eliane Tabea and Ignatov, Atanas},
title = {Placental COL1A2 and COL11A1 mRNA Expression and Collagen Type I Distribution in Spontaneous Preterm Birth, Preeclampsia, and HELLP Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10064},
doi = {10.3390/ijms272210064}
}
EUVIMED